China's pharmaceutical companies are exploring paid promotion inside the AI assistants that doctors now consult for clinical answers, after a corruption crackdown made the traditional sales visit harder.
Artificial intelligence could become a new promotion tool for the pharmaceutical industry. China's drug producing companies are exploring the possibility of paying for studies and information about their products to appear directly in responses generated by AI-based healthcare providers. The initiative comes at a time when Chinese authorities have tightened controls [...]
Artificial intelligence could become a new channel for promoting medicines to doctors. In China, pharmaceutical companies explore the possibility of paying for the inclusion of studies and information about their products in responses generated by AI medical assistants.